Bio-Techne (TECH) Accounts Payables (2010 - 2026)

Bio-Techne's Accounts Payables history runs 17 years deep, the most recent figure standing at $23.5 million for Q1 2026.

• In Q1 2026, Accounts Payables fell 25.77% year-over-year to $23.5 million; the TTM figure through Mar 2026 stood at $23.5 million (down 25.77% YoY), while the FY2025 annual figure was $25.3 million, down 33.34% from the prior year.
• Accounts Payables for Q1 2026 stood at $23.5 million, down from $26.3 million in the prior quarter.
• The five-year high for Accounts Payables was $38.0 million in Q2 2024, with the low at $23.5 million in Q1 2026.
• The 5-year median for Accounts Payables is $30.2 million (2025), against an average of $29.4 million.
• The sharpest annual moves came in 2024 and 2025: Accounts Payables jumped 47.86% in 2024, then sank 33.34% in 2025.
• Bio-Techne's Accounts Payables stood at $24.1 million in 2022, then jumped by 30.76% to $31.5 million in 2023, then gained by 5.1% to $33.1 million in 2024, then dropped by 20.69% to $26.3 million in 2025, then decreased by 10.58% to $23.5 million in 2026.
• Business Quant data shows TECH's Accounts Payables at $23.5 million in Q1 2026, $26.3 million in Q4 2025, and $30.2 million in Q3 2025.